Schiarisanrin A

CAS No. 130252-41-4

Schiarisanrin A( ——— )

Catalog No. M39050 CAS No. 130252-41-4

Schiarisanrin A (Kadsulignan J) is a lignan with inhibitory activity on NO production. Schiarisanrin A inhibits NO production in BV-2 cells with an IC50 of 9.6 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Schiarisanrin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Schiarisanrin A (Kadsulignan J) is a lignan with inhibitory activity on NO production. Schiarisanrin A inhibits NO production in BV-2 cells with an IC50 of 9.6 μM.
  • Description
    Schiarisanrin A (Kadsulignan J) is a lignan with inhibitory activity on NO production. Schiarisanrin A inhibits NO production in BV-2 cells with an IC50 of 9.6 μM.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    130252-41-4
  • Formula Weight
    484.54
  • Molecular Formula
    C27H32O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fang L, et al. Lignans from the roots of Kadsura coccinea and their inhibitory activities on LPS-induced NO productionJ. Phytochemistry Letters, 2014, 9: 158-162.
molnova catalog
related products
  • Dodecyl isobutyrate

    Dodecyl isobutyrate (Dodecyl 2-methylpropanoate) is a compound found in Jatropha curcas that causes an escape reaction in thrips.

  • AF 399

    AF 399 is a CCR4 antagonist. It reverses the tumor-promoting environment.

  • Mesna

    Mesna(Uromitexan, Mesnex), a sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents.